These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex. Jadhav GS, Vavia PR. Int J Pharm; 2008 Mar 20; 352(1-2):5-16. PubMed ID: 18023545 [Abstract] [Full Text] [Related]
16. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives. Dollo G, Le Corre P, Chollet M, Chevanne F, Bertault M, Burgot JL, Le Verge R. J Pharm Sci; 1999 Sep 20; 88(9):889-95. PubMed ID: 10479350 [Abstract] [Full Text] [Related]
17. Formation of natamycin:cyclodextrin inclusion complexes and their characterization. Koontz JL, Marcy JE. J Agric Food Chem; 2003 Nov 19; 51(24):7106-10. PubMed ID: 14611179 [Abstract] [Full Text] [Related]
20. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin. Kim JH, Lee SK, Ki MH, Choi WK, Ahn SK, Shin HJ, Hong CI. Int J Pharm; 2004 Mar 19; 272(1-2):79-89. PubMed ID: 15019071 [Abstract] [Full Text] [Related] Page: [Next] [New Search]